J Cancer 2021; 12(13):3976-3996. doi:10.7150/jca.47695 This issue Cite

Review

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer

Shuna Liu1,2, Ming Wu1,2, Fang Wang1,2✉

1. Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 210029.
2. National Key Clinical Department of Laboratory Medicine, Nanjing, China, 210029.

Citation:
Liu S, Wu M, Wang F. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. J Cancer 2021; 12(13):3976-3996. doi:10.7150/jca.47695. https://www.jcancer.org/v12p3976.htm
Other styles

File import instruction

Abstract

Graphic abstract

Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is a combination of platinum and paclitaxel chemotherapy based on surgery. The recurrence and progression of ovarian cancer with poor prognosis is a major challenge in treatment. With rapid advances in technology, understanding of the molecular pathways involved in ovarian cancer recurrence and progression has increased, biomarker-guided treatment options can greatly improve the prognosis of patients. This review systematically discusses and summarizes existing and new information on prognostic factors and biomarkers of ovarian cancer, which is expected to improve the clinical management of patients and lead to effective personalized treatment.

Keywords: ovarian cancer, prognostic factor, biomarker


Citation styles

APA
Liu, S., Wu, M., Wang, F. (2021). Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. Journal of Cancer, 12(13), 3976-3996. https://doi.org/10.7150/jca.47695.

ACS
Liu, S.; Wu, M.; Wang, F. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. J. Cancer 2021, 12 (13), 3976-3996. DOI: 10.7150/jca.47695.

NLM
Liu S, Wu M, Wang F. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. J Cancer 2021; 12(13):3976-3996. doi:10.7150/jca.47695. https://www.jcancer.org/v12p3976.htm

CSE
Liu S, Wu M, Wang F. 2021. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. J Cancer. 12(13):3976-3996.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image